Skip to content

Effectiveness of Repetitive Peripheral Magnetic Stimulation on Lower Limb Spasticity in Spastic Hemiparetic Stroke Patient: Double-blind Randomized Controlled Trial (Patient and Assessor Blind)

Effectiveness of Repetitive Peripheral Magnetic Stimulation on Lower Limb Spasticity in Spastic Hemiparetic Stroke Patient: Double-blind Randomized Controlled Trial (Patient and Assessor Blind)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200414002
Enrollment
24
Registered
2020-04-14
Start date
2020-04-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Spasticity in Spastic Hemiparetic Stroke Patient Spasticity&#44

Interventions

Repetitive Peripheral magnetic stimulation ( rPMS) (Salus&#45
Talent Pro) with active coil at gastrocnemius&#45
soleus muscle in paretic side,Repetitive Peripheral magnetic stimulation ( rPMS) (Salus&#45
Talent Pro) with non&#45
active coil at gastrocnemius&#45
soleus muscle in paretic side
Experimental Device,Sham Comparator Device
Repetitive Peripheral magnetic stimulation ( rPMS) ,Sham

Sponsors

Ratchadapiseksompotch Fund, faculty of medicine, Chulalongkorn university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. All stage of stroke patient (ischemic or hemorrhagic) which MAS of Gastrocnemius-soleus muscle between 1+ and 3 2. No ankle contracture on the affect side 3. Age 18 – 75 years old 4. Have not been treated with rPMS 5. Inform consent signed

Exclusion criteria

Exclusion criteria: 1. History of neurolytic injection within 6 months 2. History of dose adjustment of antispastic medication within 3 months 3. Contraindication of rPMS 3.1) Pregnancy 3.2) Fever 3.3) External wound, cancer, DVT or unstable fracture or metallic implant in the treatment area 3.4) Patient with electronic and/or magnetic device (cardiac pacemaker, cochlea implant, medication pumps or programmable VP shunt)

Design outcomes

Primary

MeasureTime frame
MAS of Gastrocnemius-soleus muscle At 0 week, at 1 week after PT (before intervention) and within 1 week after complete protocol Manual

Secondary

MeasureTime frame
H-reflex of Gastrocnemius-soleus muscle at 1 week after PT (before intaervention) and within 1 week after complete protocol Electrodiagnosis

Countries

Thailand

Contacts

Public ContactKwanyupa Sukonthamarn

Faculty of medicine, Chulalongkorn university

kwanyupa@gmail.com022564433

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026